Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Explore ways to budget on zero income by listing must-haves, tracking every expense, and establishing a foundation for recovery.
15,882 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Oracle rides a rebound in AI spending with a hefty backlog and cloud growth; a 12-month target suggests meaningful up...
Windfalls from settlements and inheritances are surging in 2026, but experts warn these gains often fade within a few...
Looking for a meaningful tech stock investment with a modest starting stake? Here is a practical case for Uber as the...
GlobalFoundries stock skyrocketed this week as quantum computing initiatives and government backing boosted optimism....
U.S. stocks moved higher as traders shrugged off renewed fighting in Iran, with gains led by technology and consumer ...
As Baozun charts its path in 2026, investors want clarity on revenue growth, margins, and strategic bets. This articl...
American Superconductor surprised on the top line but traded lower as short-sellers reared their heads. This article ...
NVIDIA sits atop market caps, but size isn’t the same as influence. This article breaks down what 'largest' means, wh...
Solana has faced headwinds, but many investors wonder if solana about have biggest could finally arrive in the second...
Chipmakers led U.S. equities higher, helping the S&P 500 reach a new close. This piece breaks down what moved markets...
In June's trading session, the market showed a tug-of-war between growth and value. Broadcom’s weaker AI-chip outlook...